Made available in DSpace on 2014-06-11T19:23:46Z (GMT). No. of bitstreams: 0 Previous issue date: 2007-02-23Bitstream added on 2014-06-13T18:19:59Z : No. of bitstreams: 1 brum_am_me_jabo.pdf: 342441 bytes, checksum: 76ea043eafca848acccc425ff6c78e8f (MD5) / Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) / A dopamina e um composto endogeno amplamente utilizado em terapia intensiva. Possui um amplo espectro de acoes, tanto sobre o sistema cardiovascular como urinario. Aumento da taxa de filtracao glomerular, do fluxo sanguineo renal e excrecao fracionada de sodio e fosforo sao efeitos renais esperados em individuos normais, porem sao pouco explorados na medicina veterinaria. Com o proposito de testar a hipotese que a dopamina e capaz de aumentar a excrecao fracionada de fosforo em caes nefropatas, este estudo foi conduzido. Diferentes doses de dopamina foram administradas em caes nefropatas. Avaliacoes laboratoriais foram realizadas durante e apos os tratamentos. O clearance de creatinina e a excrecao fracionada de fosforo apresentaram aumento dose-dependente nos caes sadios. Em caes nefropatas, a dose de 1 Êg/kg/min aumentou discretamente a TFG, alem de aumentar o volume urinario e excrecao de fosfato, sem modificar a U-P/C e pressao arterial sistemica, enquanto a dose de 3 Êg/kg/min nao aumentou os beneficios e, ainda, promoveu aumento da excrecao urinaria de proteinas. / Dopamine is a endogenous compound largely used in critical care. It has a large spectrum of actions on cardiovascular and urinary systems. Increases in glomerular filtration rate, renal blood flow and frational excretion of sodium and phosphate are renal effects expected in healthy patient, but there are few reports in veterinary medicine. In order to test the hypothesis that dopamine can increase frational excretion of phosphate in nephropathy dogs this study was conducted. Different dopamine doses were administered in nephropathy dogs. Laboratory evaluations were done during and after treatments. Creatinin clearance and frational excretion of phosphate increases dose-dependent form in healthy dogs. In the nephropathy dogs, the dose of 1ìg/kg/min increased the glomerular filtration rate, urinary volume and phosphate excretion, without modified U-P/C and systemic arterial blood pressure, while the dose of 3ug/kg/min don t increased the benefits and promoted a increase in the urinary excretion of proteins.

Orientadores: Susanne Rath, Jarbas Jose Rodrigues Rohwedder / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Quimica / Made available in DSpace on 2018-08-09T10:51:51Z (GMT). No. of bitstreams: 1 Winter_Eduardo_D.pdf: 3366512 bytes, checksum: 6c8baea3dd6502c19761ad449683bb95 (MD5) Previous issue date: 2007 / Resumo: Muitas doenças neurodegenerativas são associadas com disfunções de neurotransmissores, em particular catecolaminas, no cérebro. Numerosas pesquisas têm indicado que íons metálicos podem induzir estresse oxidativo - dependente da neurodegeneração de dopamina e são responsáveis pelo aparecimento de doenças neurodegenerativas. Em estudos prévios foi verificado que alguns carboxilatos diminuem a velocidade de oxidação de catecolaminas e inibem a passivação de eletrodos sólidos durante a análise voltamétrica destes compostos fenólicos. Este trabalho teve por objetivo estudar a influência de carboxilatos (EDTA, NTA, EGTA, DTPA, acetato, citrato e oxalato) e íons metálicos (Ce(IV), Fe(III) e Hg(II)) durante a oxidação de neurotransmissores (dopamina, serotonina, epinefrina, norepinefrina e L-dopa) no intuito de estabelecer mecanismos de reações que possam contribuir no esclarecimento do papel destes compostos no processo de degeneração dos neurotransmissores, assim como compreender como os carboxilatos inibem o envenenamento do eletrodo durante a varredura de potencial. Para eses propósitos foram empregadas as técnicas de espectrofotometria, voltametria e espectroeletroquímica. A cela espectroeletroquímica de camada delgada desenvolvida incorporou um sistema de três eletrodos, sendo o eletrodo de trabalho uma minigrade de Pt. O sistema foi caracterizado usando o-tolidina e K4[Fe(CN)6]/ K3[Fe(CN)6] e permitiu o monitoramento das reações in situ. Os resultados obtidos mostraram que os carboxilatos desprotonados interagem com os produtos intermediários formados durante a oxidação das catecolaminas por meio de ligações de hidrogênio, sendo estas interações dependentes do pH do meio, estruturas do carboxilato e do próprio neurotransmissor. Foi proposto um mecanismo eletroquímico para a oxidação de aminas biogênicas na presença de carboxilatos no eletrodo de platina. A estabilização dos produtos intermediários formados inibe a formação de compostos poliméricos que são responsáveis pelo envenenamento do eletrodo. Do mesmo modo, os carboxilatos retardam ou inibem a oxidação química de algumas aminas biogênicas por íons metálicos / Abstract: Several neurological disorders are associated with improper catechoalmine regulation in the brain. Numerous researches have indicated that metallic ions can induce oxidative stress-dependent neurodegeneration of dopamine, and are responsible for the induction of neurodegenerative diseases. In previous work was verified that some carboxylates diminishes the oxidation rate of catecholamines and inhibit the well known solid state electrode passivation during voltammetric analysis of these phenolic compounds. The aim of this work was to study the influence of carboxylates (EDTA, NTA, EGTA, DTPA, acetate, oxalate and citrate) and metallic ions (Ce(IV), Fe(III) and Hg(II)) during the oxidation of neurotransmitters (dopamine, serotonin, epinephrine, norepinephrine and L-dopa) in order to establish putative reaction mechanism which could contribute to understand the role of these compounds in neurodegenerative processes, as well as comprehend how the carboxylates inhibit the electrode fouling during potential scan. For these purposes, the studies were carried out using spectrophotometric, voltammetric and spectroelectrochemical techniques. The spectroelectrochemical thin layer cell developed incorporated a three electrode system, using a Pt- minigrade as working electrode. The system was characterized employing o-tolidine and K4[Fe(CN)6]/ K3[Fe(CN)6] and allowed monitoring the electrode reactions in situ. The results obtained showed that the deprotonated carboxylates interacts with the intermediates formed at the electrochemical oxidation of catecholamines by hydrogen bonds. These interactions are dependent on the pH of the medium, as well as on the chemical structures of the carboxylates and neurotransmitters itself. An electrochemical mechanism for the oxidation of biogenic amines in the presence of carboxylates at the platinum electrode is proposed. The stabilization of the intermediates formed inhibits the formation of polymeric compounds that are responsible for the electrode fouling. In the same manner, the carbolxylates retards or inhibit the chemical oxidation of some biogenic amines by metallic ions by the same reaction pathway / Doutorado / Quimica Analitica / Doutor em Ciências

Chronic pain induced by nerve damage due to trauma or invasion of cancer to the bone elicits severe ongoing pain as well as hyperalgesia and allodynia likely reflecting adaptive changes within central circuits that amplify nociceptive signals. The present study explored the possible contribution of the mesolimbic dopaminergic circuit in promoting allodynia related to neuropathic and cancer pain. Mice with ligation of the sciatic nerve or treated with intrafemoral osteosarcoma cells showed allodynia to a thermal stimulus applied to the paw on the injured side. Patch clamp electrophysiology revealed that the intrinsic neuronal excitability of ventral tegmental area (VTA) dopamine neurons projecting to the nucleus accumbens (N.Acc.) was significantly reduced in those mice. We used tyrosine hydroxylase (TH)-cre mice that were microinjected with adeno-associated virus (AAV) to express channelrhodopsin-2 (ChR2) to allow optogenetic stimulation of VTA dopaminergic neurons in the VTA or in their N.Acc. terminals. Optogenetic activation of these cells produced a significant but transient anti-allodynic effect in nerve injured or tumor-bearing mice without increasing response thresholds to thermal stimulation in sham-operated animals. Suppressed activity of mesolimbic dopaminergic neurons is likely to contribute to decreased inhibition of N.Acc. output neurons and to neuropathic or cancer pain-induced allodynia suggesting strategies for modulation of pathological pain states.

No description available.

Dopamine (DA) is a key striatal neuromodulator central to normal functioning of the basal ganglia. Identifying and characterizing circuits governing striatal DA transmission is necessary for understanding DA involvement in adaptive behaviour and pathology. Properties of evoked striatal DA release can be examined using fast-scan cyclic voltammetry at carbon fibre microelectrodes, a technique enabling live monitoring of transmitter release events with sub-millisecond resolution. Experimental work presented in this thesis employed this approach to study regulation of striatal DA by acetylcholine (ACh) in health and disease in acute brain slices. Synchronous activity in a small population of striatal cholinergic interneurons (ChIs) was previously shown to directly drive striatal DA release. Here using optogenetic approach I explore physiological relevance of ChI-evoked drive of striatal DA by examining whether corticostriatal and thalamostriatal afferents to ChIs can trigger ACh-evoked DA events. Following floxed vector injections in motor cortex or caudal intralaminar thalamus of CaMK2a-Cre mice I examine the properties of evoked DA upon light activation of channelrhodopsin-2-transduced inputs to striatal ChIs. These experiments revealed that both cortical and thalamic afferents are capable of driving ACh-evoked DA release, but operate using a different complement of post-synaptic ionotropic glutamate receptors and display distinct release recovery profiles. I further explore if rebound excitation in a population of striatal ChIs could drive DA events by examining whether ACh-evoked DA release follows optical inhibition of striatal ChIs selectively expressing hyperpolarizing halorhodopsin 3.0 or archaerhodopsin 3.0 in ChAT-Cre mice. This work showed that hyperpolarizing ion pumps were not successful in triggering ChI-evoked DA release. I also investigate whether cholinergic brainstem innervation of striatum could contribute to or drive ACh-evoked striatal DA events in ChAT-Cre rat, concurrently showing that ChI-evoked DA release is not a species artefact, and is present in mouse and rat alike. Current results also suggest that cholinergic brainstem afferents do not drive or contribute to striatal ACh-evoked DA events. Close interaction between DA and ACh systems further indicates that ACh could impact dopaminergic dysfunction. To explore this I examined the state of ACh transmission in a mouse model of Parkinson’s disease overexpressing human wild type alpha–synuclein protein. These animals present with impaired striatal DA release from young age, but DA deficits could be mediated by changes in ACh tone. Here I show that impaired striatal DA release is the results of primary DA axon dysfunction, although in ventral striatum DA release deficits could be partially compensated by increased ACh tone at nicotinic receptors. I further show that the functional state of muscarinic ACh receptors in not altered following decreased DA transmission, although the data from aged animals suggest that alpha–synuclein-dependent changes in vesicle handling could contribute to impaired DA releasability. Finally, I show that vesicle handling may indeed be altered in this mouse model as impaired DA release is evident with short stimulation protocols, while with prolonged depolarization of DA axon terminals alpha–synuclein-overexpressor mice are better able to sustain evoked DA release. Overall, the main body of work presented in this thesis examined the processes regulating striatal DA transmission via ACh system. In particular, I show that ChI-evoked drive of striatal DA release can be recruited physiologically and further establish that changes in ACh transmission are not the primary drivers of impaired DA releasability in a mouse model of Parkinson’s disease overexpressing human alpha–synuclein protein.

Dopamine (DA) is a key neuromodulator in the striatum, and is important for action selection and reinforcement learning. Dysfunctions in striatal DA signalling contribute to numerous disorders including Parkinson’s disease (PD) and drug addiction. Midbrain DA neurons switch from low to high frequency firing in response to reward-related events, which is proposed to increase striatal DA release. However, in addition to DA neuron firing pattern, striatal DA signalling depends upon the short-term plasticity of DA release, which is controlled by presynaptic and local network factors. This thesis uses fast-scan cyclic voltammetry, in murine striatal slices, to detect subsecond changes in extracellular DA, and investigate the presynaptic control of striatal DA release and release plasticity. Acetylcholine from striatal cholinergic interneurons, acting at nicotinic receptors (nAChRs) on DA terminals, is one factor that strongly influences DA release. This thesis particularly explores how presynaptic factors interact with nAChRs to control DA release. Firstly, release probability, a key determinant of release plasticity at many synapses, was found to be only weakly related to DA release plasticity, and only when nAChRs are inactive. Secondly, a direct role of the DA uptake transporter (DAT) in controlling DA release plasticity was identified, when nAChRs are inactive. Thirdly, regional differences were identified in the role of the DAT in controlling DA release via control of D2 receptor activation, when nAChRs are active. Finally, mutant α-synuclein, which causes PD in humans, was found to only subtly affect striatal DA release. These data suggest that the control of striatal DA release differs substantially from other central transmitters. Release probability and α-synuclein play only minor roles, but nAChRs and the DAT significantly control DA release plasticity. These findings review our understanding of striatal DA release and may have implications for understanding the actions of drugs of abuse and early PD pathogenesis.

Recent approaches in depression therapeutics include triple reuptake inhibitors, drugs that target three monoamine systems. Using in vivo electrophysiological and microdialysis techniques, the effects of 2- and 14-day treatments of escitalopram, nomifensine and the co-administration of these two drugs (TRI) were examined in male Sprague-Dawley rats. Short- and long-term TRI administration decreased NE firing and had no effect on DA neurons. Normal 5-HT firing rates were maintained after 2-day TRI administration compared to the robust inhibitory action of selective serotonin reuptake inhibitors (SSRIs). Escitalopram treatment enhanced the tonic activation of the 5-HT1A receptors given the increase in firing observed following WAY100635 administration. Nomifensine treatment enhanced tonic activation of the α2–adrenoceptors following idazoxan administration. TRI treatment caused a robust increase in extracellular DA levels that was in part mediated by a serotonergic contribution. Therapeutic effects of the drugs examined in this study may be due to the enhancement of 5-HT, NE and/or DA neurotransmission.

Parkinson’s disease (PD) is characterized by the progressive loss of dopamine (DA) neurons in the substantia nigra pars compacta (SNc). Mechanisms regulating this neurodegeneration, however, are unclear. Evidence from PD pathology and models of PD, indicate mitochondrial disfunction triggers several death signalling pathways. Accordingly, in vivo and in vitro mitochondrial stress models of PD were employed to explore the role of two divergent molecular influences on dopaminergic neuronal survival. We examined neuroinflammatory and death signalling pathways arising from MPTP-induced mitochondrial stress. Interferon-gamma (IFN-ɣ) is a cytokine known to activate cellular components of inflammation, including microglia of the central nervous system (CNS). Results of a screen for cytokines in PD patient plasma revealed elevated levels of IFN-ɣ, suggesting a correlation between IFN-ɣ and PD associated DA cell death. In an MPTP mouse model of PD, germline deletion of IFN-ɣ improved survival of DA neurons and the nigrostriatal system, along with a reduction in microglia activation. Employing a survival co-culture system of neurons and microglia, it was found that neutralizing IFN-ɣ reduced DA cell loss induced by the mitochondrial complex I inhibitor, rotenone. DA cell death required localized microglia, activated through the IFN-ɣ-receptor (IFN-ɣ-R), with DA survival inversely proportional to IFN-ɣ expression, found to be up-regulated following rotenone. Investigation of the calpain-Cdk5-MEF2 signalling pathway in the MPTP model of DA cell death, motivated an examination of the nuclear orphan receptor, Nur77, following a review of potential MEF2 regulatory targets. MPTP induced a reduction in Nur77 mRNA from basal ii levels in SNc tissue, further regulated by ectopic Nur77 expression. These results strengthened our new model of MEF2 Nur77 regulation in DA neurons. In MPP+/MPTP DA survival experiments, loss in germline Nur77 expression presented an elevation in DA neuronal death both in vitro and in vivo, with a greater impairment in the nigrostriatal circuitry in comparison with normal expressing animals and cells. Dopaminergic supersensitivity related to Nur77 deficiency was attenuated with the ectopic expression of AV-Nur77 in vivo. These opposing mediators of survival yield new mechanisms by which DA neurons die, suggesting a mutitargeting approach to halt the progression of DA cell death.

The adolescent period has been proposed to be exquisitely sensitive to the impacts of stress and juvenile stressor exposure is associated with anxiety- and depressive- like characteristics in adulthood. Among adult rats, access to a palatable diet has shown to mitigate the effects of stressors, a form of ‘self-medication.’ The present collection of studies sought to further characterize the long-term consequences of stressor exposure early in the juvenile period, as well as the use of palatable food as a coping strategy. The first study (Chapter 2) highlighted the importance of methodological rigor in the design of experiments employing social stressors. The second study (Chapter 3) provided further evidence that exposure to juvenile social defeat can have long-lasting consequences into adulthood, and access to a palatable diet may impart some resilience to initial stressor exposure. The third study (Chapter 4) demonstrated that access to a palatable diet can mitigate the long-term behavioral consequences of a 3-day sub chronic non-social stressor applied during juvenility in pair housed rats. The fourth study (Chapter 5) sought to replicate these findings in individually housed (purportedly more stressed) animals. Interestingly, access to a palatable diet was sufficient to protect against the neuroendocrine consequences of juvenile stress but did not mitigate the behavioral consequences, raising the question of an effectiveness “threshold” of self-medication via a palatable diet. The final study (Chapter 6) provided some preliminary evidence that exposure to juvenile stress amid access to a palatable diet has long-lasting changes on dopamine receptor expression in the nucleus accumbens, although the functional significance needs further characterization. Collectively, all studies provided further evidence that self-medication with a palatable diet comes at the price of poor metabolic outcomes. The results of this body of work provide further evidence that exposure to stress during juvenility can have protracted effects into adulthood, at the cost of poor metabolic outcomes. It also raises the suggestion of an effectiveness threshold of palatable food to cope with stress. Further understanding of the interplay between stress and diet may serve to inform the development of prevention based programs to mitigate the rising tide of concurrent childhood obesity and levels of perceived stress.

The recent decline and disappearance of many amphibians around the world is thought to be the sign of an impending sixth mass extinction that is driven by disease, habitat loss and pollution. Reproductive technologies are now required to establish captive colonies followed by reintroduction into suitable habitats. The AMPHIPLEX method is a hormone mixture that has successfully stimulated spawning in several amphibians. However, its extensive application requires further experimentation and knowledge regarding the basic neuroendocrine control of reproduction in amphibians. The role of the catecholamine neurotransmitter dopamine in the regulation of spawning and gonadotropin synthesis was investigated using multiple time- and dose-related approaches in the field and laboratory. These end points were explored in two distantly-related frog species: the Northern leopard frog (Lithobates pipiens) and the Western clawed frog (Silurana tropicalis). Northern leopard frogs were injected during the natural breeding season with three doses of a gonadotropin-releasing hormone agonist (GnRH-A) (0.1 μg/g , 0.2 μg/g and 0.4 μg/g) alone and in combination with two doses of the selective dopamine receptor D2 antagonist metoclopramide (MET) (5 μg/g and 10 μg/g). Injected animals were allowed to breed in mesocosms in an outdoor field. Time to amplexus and oviposition were assessed, and egg mass release, incidences of amplexus, egg mass weight, total egg numbers and fertilization rates were measured. The results revealed no statistically significant interaction between GnRH-A and MET on amplexus and oviposition. A series of GnRH-A dose-response spawning studies were conducted in the Western clawed frog. The current findings indicate that partial ovulation, male sexual behavior and fertilization can be induced by 4 μg/g of GnRH-A alone and in combination with 10 μg/g of MET. This represents a first step towards understanding basic neuroendocrine reproductive mechanisms in this species. These spawning results were paired with a second end point which explored the molecular mechanisms of gonadotropin synthesis in response to GnRH-A and MET alone and in combination. Pituitary gene expression results in the Northern leopard frog indicate a potentiating action of MET when combined with GnRH-A on the mRNA levels of gonadotropin subunits 36 hours following injection. The postulated mechanisms of action are through the upregulation of gonadotropin-releasing hormone receptor 1 and the downregulation of dopamine receptor D2. Such gene expression pathways were similarly explored in the Western clawed frog, however no significant changes in pituitary gonadotropin and receptor gene expression were present at 12 hours post-injection. The hypothesized inhibitory action of dopamine was supported by pituitary gene expression analysis, but not by spawning outcome. The results from this study provide a fundamental framework for future time- and dose-response investigations to improve current spawning methods in amphibians.